AULTMAN HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $4.7M
- Transactions
- 792
- Companies
- 40
- Average per transaction
- $5,977
Who reported the payments
| Novartis | $912,698 |
| Amgen | $518,732 |
| Merck | $485,801 |
| AstraZeneca | $483,830 |
| GSK | $407,175 |
| Tesaro, Inc. | $405,961 |
| Eli Lilly | $350,199 |
| Boston Scientific | $260,887 |
| Astrazeneca UK Limited | $225,974 |
| American Regent | $99,075 |
| Pfizer | $88,386 |
| CSL Behring | $64,850 |
| Kowa Research Institute, Inc. | $62,193 |
| Genentech, Inc. | $40,417 |
| E.r. Squibb & Sons, L.L.C. | $26,727 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | $22,771 |
| Siemens Medical Solutions USA, Inc. | $22,769 |
| Abbott | $21,884 |
| Esperion Therapeutics, Inc. | $20,922 |
| Biosense Webster, Inc. | $20,244 |
| Medical Device Business Services, Inc. | $16,350 |
| Novocure GmbH | $14,000 |
| Boehringer Ingelheim International GmbH | $11,669 |
| Ionis Pharmaceuticals, Inc. | $10,272 |
| GE HealthCare | $8,476 |
| Gilead | $7,600 |
| KCI USA, Inc. | $7,125 |
| Sterilmed, Inc. | $6,464 |
| Daiichi Sankyo Inc. | $6,105 |
| Incyte Corporation | $5,800 |
| AbbVie | $5,700 |
| Medtronic | $5,594 |
| Lilly USA, LLC | $5,250 |
| Regeneron Healthcare Solutions, Inc. | $5,100 |
| Sanofi US Services Inc. | $5,000 |
| Boehringer Ingelheim | $4,850 |
| Olympus America Inc. | $4,346 |
| Sobi, Inc | $4,300 |
| Johnson & Johnson | $4,109 |
| Genentech USA, Inc. | $3,950 |